Status:
COMPLETED
Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock
Lead Sponsor:
Rush University Medical Center
Conditions:
Septic Shock
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
We are performing a prospective, randomized, controlled trial of dopamine versus norepinephrine for septic shock. The trial will enroll patients with suspected or documented site of infection and havi...
Detailed Description
Research Question/Hypothesis: The initial selection of the vasopressor norepinephrine in comparison to dopamine will result in a decrease in mortality for patients in septic shock. Study Design/Sourc...
Eligibility Criteria
Inclusion Criteria:
- Patients are transferred to our medical intensive care unit from the emergency room (ER), general medical floors, and from outside hospitals.
- Patients were eligible if they were greater than 18 years of age
- Presented with a diagnosis of SIRS plus a suspected or documented source of infection.
Exclusion Criteria:
- Patients were not eligible if they were found to have hypovolemic and/or hemorrhagic etiologies of their vasodilatory shock or another etiology of their SIRS.
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
252 Patients enrolled
Trial Details
Trial ID
NCT00604019
Start Date
March 1 2003
End Date
August 1 2009
Last Update
January 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RUSH University Medical Center
Chicago, Illinois, United States, 60612